Drug intelligence / Profile preview

ELF4 siRNA

Development stage
Preclinical
Lead developer
Chung Shan Medical University
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous
01

Overview

ELF4 siRNA is a small interfering RNA designed to silence the expression of the E74-like ETS transcription factor 4 (ELF4). ELF4 is a member of the ETS family of transcription factors and has been implicated in the progression of various cancers, including endometrial cancer. By targeting ELF4 mRNA for degradation, ELF4 siRNA reduces the levels of ELF4 protein, which in turn inhibits the interaction between ELF4 and tribbles pseudokinase 3 (TRIB3). This interaction is known to regulate the expression of downstream targets such as CDK6 and β-catenin, which are critical for cell cycle progression, proliferation, and the maintenance of cancer stem cell (CSC) activity. In preclinical models of endometrial cancer, treatment with ELF4 siRNA has been shown to attenuate tumor growth, migration, and invasion.

Other names
siELF4siELF-4siELF 4ELF4 small interfering RNAELF-4 small interfering RNAELF 4 small interfering RNA
02

Targets

ETS (ETS transcription factor family)Innate immune RNA sensors

Beyond the preview

Go deeper on ELF4 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ELF4 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call